NCT04636372|Withdrawn
Study Stopped
An one-month follow-up was completed after the treatment.
Loading search results
An one-month follow-up was completed after the treatment.
Sponsor study identifier
interventional
0
0 countries
N/A
Study Start
September 1, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
January 31, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
January 31, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
200 participants at Eye Hospital of Wenzhou Medical University during September, 2020 to November, 2020 will be enrolled in this study. The meibomian gland related therapy are pulsed light therapy and meibomian gland hot compress massage.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 31, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 1, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
September 30, 2020
Actual (reported)November 19, 2020
Actual (reported)January 31, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
January 31, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The length of meibomian glands after the treatment.
Length in millimeters.
up to 2 months
The area of meibomian glands after the treatment.
Area in millimeters\^2.
up to 2 months
The percentage of meibomian glands after the treatment.
Percentage of meibomian glands in %(area of meibomian glands (mm\^2) and area of palpebral conjunctiva (mm\^2) will be combined to report percentage of meibomian glands in %) are used to assess this outcome measure.
up to 2 months
Patients with xerophthalmia were treated with intense pulsed light of meibomian gland.
Patients with xerophthalmia were treated with hot compress massage of meibomian gland.
0 participants (actual enrollment reported by the registry).
First Submitted
September 30, 2020
First Posted
November 19, 2020
Study Start
September 1, 2020
Estimated (date passed)Use of Autologous Serum Eye-drops as Tears in Patients With Recalcitrant Dry Eye
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
January 31, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
January 31, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
November 19, 2020
Record last verified: 2020-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: